Aug 3 (Reuters) - Emergent Biosolutions Inc:
* Emergent Biosolutions reports second quarter and six months 2017 financial results; reaffirms calendar year 2017 guidance
* Q2 earnings per share $0.11
* Q2 revenue $100.8 million versus I/B/E/S view $111.6 million
* Q2 earnings per share view $0.26 -- Thomson Reuters I/B/E/S
* Emergent Biosolutions Inc sees full year 2017 total revenue of $500 to $530 million
* Emergent Biosolutions Inc sees full year 2017 GAAP net income of $60 to $70 million
* Emergent Biosolutions Inc sees full year 2017 adjusted net income of $70 to $80 million
* Fy2017 revenue view $510.0 million -- Thomson Reuters I/B/E/S
* Emergent Biosolutions Inc - for full year of 2017 company is reaffirming its financial forecast Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.